Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06264336 · ClinicalTrials.gov registry record · NA

Effects of High-intensity Gait Training on Fatigue, Gait, and Neuroplasticity in People With Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by University of Illinois at Chicago.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06264336 is a NA study of Multiple Sclerosis that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 20 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06264336, a NA study of Multiple Sclerosis, is actively recruiting participants, sponsored by University of Illinois at Chicago.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Nearly 1 million individuals in the United States have multiple sclerosis, which causes fatigue and problems with walking. Fatigue and walking problems are poorly treated, but exercise training, particularly high-intensity walking exercise, may help. This provide insight into whether high-intensity walking exercise can improve fatigue and walking problems in people with multiple sclerosis, which could improve quality of life and reduce economic burden.

Conditions Studied

Interventions

  • BEHAVIORAL treadmill training

Study Locations (1)

Illinois

  • University of Illinois Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-03-01
Est. Completion 2025-12-31
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT06264336

The ClinicalTrials.gov registry entry for NCT06264336 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which treadmill training is the first listed.

NCT06264336 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06264336 about?

NCT06264336 is a clinical study titled "Effects of High-intensity Gait Training on Fatigue, Gait, and Neuroplasticity in People With Multiple Sclerosis". Nearly 1 million individuals in the United States have multiple sclerosis, which causes fatigue and problems with walking. Fatigue and walking problems are poorly treated, but exercise training, particularly high-intensity walking exercise, may help. This provide insight into whether high-intensity ...

What is the current status of trial NCT06264336?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-03-01. Estimated completion is 2025-12-31.

What conditions does trial NCT06264336 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT06264336?

The interventions under investigation include: treadmill training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06264336?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06264336 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.